(NP (NP (JJ Severe) (JJ combined) (NN immunodeficiency)) (PP (IN due) (TO to) (NP (NP (JJ defective) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ nuclear) (NN factor)) (PP (IN of) (NP (NP (VBN activated) (NN T) (NNS cells)) (PP (IN in) (NP (NP (NN T) (NNS lymphocytes)) (PP (IN of) (NP (CD two) (JJ male) (NNS siblings))))))))))) (. .))
(S (NP-SBJ (NP-COOD (NP (NP (JJ Peripheral) (NN blood) (NNS lymphocytes)) (PRN (-LRB- -LRB-) (NP (NN PBL)) (-RRB- -RRB-))) (CC and) (NP (JJ alloreactive) (NN T) (NN cell) (NNS lines))) (PP (IN of) (NP (NP (CD two) (JJ male) (NNS infants)) (VP-COOD (VP (VBN born) (NP (-NONE- *)) (PP (TO to) (NP (JJ consanguinous) (NNS parents)))) (CC and) (VP (VBG presenting) (PP (IN with) (NP (NP (JJ severe) (JJ combined) (NN immunodeficiency)) (PRN (-LRB- -LRB-) (NP (NN SCID)) (-RRB- -RRB-))))))))) (VP (VBD showed) (NP (NP (DT a) (JJ pronounced) (NN deficiency)) (PP (IN in) (NP (NN T) (NN cell) (NN activation))))) (. .))
(S (SBAR (IN Although) (FRAG (ADJP (RB phenotypically) (JJ normal)))) (, ,) (NP-SBJ-23 (NP (DT the) (JJ proliferative) (NN response)) (PP (IN of) (NP (NP (DT the) (NNS childrens) (POS ')) (NN T) (NNS cells)))) (VP (VP-COOD (VP (VBD was) (ADVP (RB strongly)) (VP (VBN reduced) (NP (-NONE- *-23)))) (CC but) (VP (MD could) (VP (VB be) (VP (VBN improved) (NP (-NONE- *-23)))))) (PP (IN by) (NP-LGS (NP (DT the) (NN addition)) (PP (IN of) (NP (NP (NN interleukin-2)) (PRN (-LRB- -LRB-) (NP (NN IL-2)) (-RRB- -RRB-))))))) (. .))
(S (ADVP (RB Furthermore)) (NP-SBJ-25 (NP (DT both) (NNS childrens) (POS ')) (NN T) (NNS cells)) (VP (VBD were) (ADJP-PRD (JJ unable) (S (NP-SBJ (-NONE- *-25)) (VP (TO to) (VP (VB produce) (NP (DT the) (NNS cytokines) (NP-COOD (NP (NN IL-2)) (, ,) (NP (NP (NN interferon-gamma)) (PRN (-LRB- -LRB-) (NP (NN IFN-gamma)) (-RRB- -RRB-))) (, ,) (NP (NN IL-4)) (CC and) (NP (NP (NN tumor) (NN necrosis) (NN factor-alpha)) (PRN (-LRB- -LRB-) (NP (NN TNF-alpha)) (-RRB- -RRB-)))))))))) (. .))
(S (NP-SBJ-26 (DT This) (JJ multiple) (NN cytokine) (NN production) (NN deficiency)) (VP (MD could) (RB not) (VP (VB be) (VP (VBN restored) (NP (-NONE- *-26)) (PP (IN by) (NP-LGS (NP (UCP-COOD (NP (NN IL-2)) (CC or) (ADJP (JJ co-stimulatory))) (NNS signals)) (VP (VBN provided) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (JJ antigen-presenting) (NNS cells)) (PRN (-LRB- -LRB-) (NP (NN APC)) (-RRB- -RRB-)))))))))) (. .))
(S (ADVP (RB Moreover)) (, ,) (NP-SBJ-27 (NP (NN mRNA)) (PP (IN for) (NP-COOD (NP (NN IL-2)) (CC and) (NP (NN IFN-gamma))))) (VP (MD could) (RB not) (VP (VB be) (VP (VBN detected) (NP (-NONE- *-27))))) (. .))
(S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (NN expression)) (PP (IN of) (NP (DT the) (JJ activation-dependent) (NN cell) (NN surface) (NNS markers) (NP-COOD (NP (NN CD25)) (CC and) (NP (NN CD69)))))) (VP (VBD was) (PP-PRD (IN within) (NP (JJ normal) (NNS limits)))) (. .))
(S (S (NP-SBJ-29 (-NONE- *)) (VP (TO To) (VP (VB determine) (SBAR (IN whether) (S (NP-SBJ (NP (DT the) (JJ functional) (NN defect)) (PP (IN of) (NP (NP (DT the) (NNS patients) (POS ')) (NN T) (NNS cells)))) (VP (VBD was) (PP-PRD (JJ due) (TO to) (NP (NP (DT the) (NP-COOD (NP (NN absence)) (CC or) (NP (JJ abnormal) (NN binding)))) (PP (IN of) (NP (NP (NN transcription) (NNS factors)) (VP (VBN involved) (NP (-NONE- *)) (PP (IN in) (NP (NN cytokine) (NN gene) (NN expression)))))))))))))) (, ,) (NP-SBJ-28 (JJ electrophoretic) (NN mobility) (NN shift) (NNS assays)) (VP (VBD were) (VP (VBN used) (NP (-NONE- *-28)) (S (NP-SBJ (-NONE- *-29)) (VP (TO to) (VP (VB examine) (NP (NP (DT the) (NN DNA) (NN binding)) (PP (IN of) (NP-COOD (NP (NN AP-1)) (, ,) (NP (NN Oct)) (, ,) (NP (NN CREB)) (, ,) (NP (NN SP1)) (, ,) (NP (NN NF-kappa) (NN B)) (CC and) (NP (NP (NP (DT the) (JJ nuclear) (NN factor)) (PP (IN of) (NP (VBN activated) (NN T) (NNS cells)))) (PRN (-LRB- -LRB-) (NP (NN NF-AT)) (-RRB- -RRB-))))) (PP (TO to) (NP (NP (PRP$ their) (JJ respective) (NN response) (NNS elements)) (PP (IN in) (NP (NP (DT the) (NN promoter)) (PP (IN of) (NP (DT the) (NN IL-2) (NN gene))))))))))))) (. .))
(S (SBAR (IN Whereas) (S (NP-SBJ-COOD (NP (NN AP-1)) (, ,) (NP (NN NF-kappa) (NN B)) (, ,) (NP (NN Oct)) (, ,) (NP (NN CREB)) (CC and) (NP (NN SP1))) (VP (VBD displayed) (NP (NP (JJ normal) (NN binding) (NNS activities)) (PP (IN in) (NP (JJ nuclear) (NNS extracts))))))) (, ,) (NP-SBJ (NP (DT the) (NN binding)) (PP (IN of) (NP (NN NF-AT))) (PP (TO to) (NP (PRP$ its) (NN IL-2) (NN promoter) (NN response) (NN element)))) (VP (VBD was) (ADJP-PRD (RB barely) (JJ detectable)) (PP-TMP (PP-COOD (CC both) (PP (IN before) (NP (-NONE- *RNR*-30))) (CC and) (PP (IN after) (NP (-NONE- *RNR*-30)))) (NP-30 (NN T) (NN cell) (NN stimulation)))) (. .))
(S (NP-SBJ (PRP$ Our) (NNS results)) (ADVP (RB strongly)) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (DT this) (NN (DNA NF-AT)) (NN binding) (NN defect)) (VP (VBZ is) (ADJP-PRD (JJ responsible) (PP (IN for) (NP (NP-COOD (NP (DT the) (JJ multiple) (NN cytokine) (NN deficiency)) (CC and) (NP (DT the) (NN SCID) (NN phenotype))) (VP (VBN observed) (NP (-NONE- *)) (PP (IN in) (NP (DT the) (CD two) (JJ infant) (NNS brothers))))))))))) (. .))
